Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

83%

5 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 4

5(100.0%)

5Total

Phase 4(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT00831428Completed

Screening Scottish Swimmers for Asthma and Rhinitis

Role: lead

NCT00679250Phase 4Completed

To Evaluate Adenosine Monophosphate and Allergen Challenge in Allergic Rhinitis

Role: lead

NCT01194700Phase 4Completed

Comparative Study of Lung Bioavailability of HFA-Seretide Via Current Spacer Devices in Healthy Volunteers

Role: lead

NCT00487032Phase 4Completed

Differential Adrenoreceptor Mediated Tachyphylaxis and Upregulation

Role: lead

NCT00996697Phase 4Completed

Differential Trough Effects of 'Triple Therapy' on Pulmonary Function in Chronic Obstructive Pulmonary Disease (COPD)

Role: lead

NCT00846326Phase 4Withdrawn

Preventing Tolerance to Oxymetazoline in Allergic Rhinitis

Role: lead

All 6 trials loaded